Scarica l'app Stockscreener
432.89
0.39%
1.68
Dopo l'orario di chiusura:
432.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$431.21
Aprire:
$435.99
Volume 24 ore:
281.07K
Relative Volume:
0.76
Capitalizzazione di mercato:
$9.61B
Reddito:
-
Utile/perdita netta:
$-518.67M
Rapporto P/E:
-17.23
EPS:
-25.12
Flusso di cassa netto:
$-438.32M
1 W Prestazione:
-1.13%
1M Prestazione:
+27.73%
6M Prestazione:
+24.65%
1 anno Prestazione:
+75.97%
Intervallo 1D:
$428.00
$436.59
Intervallo di 1 settimana:
$422.02
$443.00
Portata 52W:
$200.63
$443.00
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
Nome
Madrigal Pharmaceuticals Inc
Settore
Industria
Telefono
404-380-9263
Indirizzo
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Confronta MDGL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDGL
Madrigal Pharmaceuticals Inc
|
432.89 | 9.61B | 0 | -518.67M | -438.32M | -25.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-28 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2025-02-27 | Reiterato | H.C. Wainwright | Buy |
| 2024-06-28 | Iniziato | Cantor Fitzgerald | Neutral |
| 2024-06-11 | Iniziato | Wolfe Research | Outperform |
| 2024-04-22 | Iniziato | BofA Securities | Underperform |
| 2024-03-15 | Aggiornamento | B. Riley Securities | Sell → Neutral |
| 2024-03-06 | Iniziato | Citigroup | Buy |
| 2024-02-26 | Downgrade | B. Riley Securities | Neutral → Sell |
| 2022-12-20 | Reiterato | Oppenheimer | Outperform |
| 2022-12-19 | Reiterato | H.C. Wainwright | Buy |
| 2022-12-19 | Reiterato | Piper Sandler | Overweight |
| 2022-12-19 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2022-07-08 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-10-07 | Iniziato | Jefferies | Buy |
| 2021-08-06 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-20 | Ripresa | Goldman | Buy |
| 2020-11-24 | Ripresa | Evercore ISI | Outperform |
| 2020-11-06 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-06-05 | Iniziato | BMO Capital Markets | Market Perform |
| 2020-05-05 | Iniziato | Chardan Capital Markets | Buy |
| 2020-01-30 | Iniziato | Canaccord Genuity | Buy |
| 2020-01-09 | Aggiornamento | UBS | Neutral → Buy |
| 2019-11-07 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-25 | Iniziato | Stifel | Hold |
| 2019-06-10 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2019-02-28 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-22 | Iniziato | SVB Leerink | Outperform |
| 2019-01-23 | Iniziato | UBS | Neutral |
| 2018-12-14 | Iniziato | Wolfe Research | Outperform |
| 2018-12-12 | Iniziato | B. Riley FBR | Neutral |
| 2018-11-19 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2018-11-16 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-09-04 | Iniziato | Citigroup | Buy |
| 2018-08-06 | Downgrade | Goldman | Buy → Neutral |
| 2018-06-28 | Iniziato | Raymond James | Mkt Perform |
Mostra tutto
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
What is the PEG ratio of Madrigal Pharmaceuticals Inc.July 2025 Chart Watch & High Yield Stock Recommendations - خودرو بانک
Does Madrigal Pharmaceuticals Inc. have consistent dividend growthTrade Signal Summary & Risk Controlled Stock Alerts - خودرو بانک
Is Madrigal Pharmaceuticals Inc. a top pick in the sectorEarnings Performance Report & Accurate Technical Buy Alerts - خودرو بانک
What is the target price for Madrigal Pharmaceuticals Inc. stockWeekly Profit Report & AI Enhanced Execution Alerts - خودرو بانک
Will Madrigal Pharmaceuticals Inc. outperform the market in YEARJuly 2025 Final Week & Real-Time Chart Breakout Alerts - خودرو بانک
Published on: 2025-09-05 14:43:14 - Newser
How sentiment analysis helps forecast Madrigal Pharmaceuticals Inc.Weekly Risk Report & AI Forecast for Swing Trade Picks - Newser
Analyzing Madrigal Pharmaceuticals Inc. with risk reward ratio chartsQuarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
How liquid is Madrigal Pharmaceuticals Inc. stock2025 Institutional Moves & AI Driven Stock Movement Reports - خودرو بانک
Is a relief rally coming for Madrigal Pharmaceuticals Inc. holdersMarket Performance Report & Verified Short-Term Trading Plans - Newser
Is Madrigal Pharmaceuticals Inc. stock trending bullishJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - خودرو بانک
Published on: 2025-09-05 06:45:41 - Newser
Can machine learning forecast Madrigal Pharmaceuticals Inc. recoveryWeekly Stock Summary & AI Forecast Swing Trade Picks - Newser
What momentum shifts mean for Madrigal Pharmaceuticals Inc.Weekly Volume Report & Daily Price Action Insights - Newser
How sentiment analysis helps forecast Madrigal Pharmaceuticals IncEntry Point & Step-by-Step Swing Trade Plans - Newser
Analyzing net buyer seller activity in Madrigal Pharmaceuticals Inc.Portfolio Return Report & Step-by-Step Trade Execution Guides - Newser
Madrigal Pharmaceuticals Announces Grants of Inducement Awards u - GuruFocus
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Madrigal Pharmaceuticals' Rezdiffra Approval Sparks Higher Price Target from TD Cowen Analyst - AInvest
TD Cowen Sees Greater Upside in Madrigal (MDGL) Following Recent Rezdiffra Approval - Yahoo Finance
MDGL: HC Wainwright & Co. Assumes Buy Rating with $500 Target | - GuruFocus
Madrigal stock rating initiated at Buy by H.C. Wainwright with $500 target - Investing.com
Real time breakdown of Madrigal Pharmaceuticals Inc. stock performance2025 Market Overview & Technical Pattern Based Signals - Newser
Is Madrigal Pharmaceuticals Inc. subject to activist investor interestJuly 2025 Setups & Daily Profit Focused Stock Screening - خودرو بانک
Technical signs of recovery in Madrigal Pharmaceuticals Inc.Portfolio Return Report & Fast Gain Stock Trading Tips - Newser
Earnings visualization tools for Madrigal Pharmaceuticals Inc.2025 Earnings Impact & Momentum Based Trading Ideas - Newser
Nasdaq Moves: Is Madrigal Pharmaceuticals Inc. stock trending bullishEarnings Performance Report & Weekly High Conviction Trade Ideas - khodrobank.com
Regression analysis insights on Madrigal Pharmaceuticals Inc. performanceInflation Watch & Verified Stock Trade Ideas - Newser
Should you hold or exit Madrigal Pharmaceuticals Inc. now2025 Volatility Report & Long-Term Growth Stock Strategies - Newser
Does Madrigal Pharmaceuticals Inc. stock benefit from AI growth2025 Stock Rankings & Smart Allocation Stock Tips - خودرو بانک
Real time social sentiment graph for Madrigal Pharmaceuticals Inc.Market Risk Report & Fast Gain Stock Trading Tips - Newser
Can Madrigal Pharmaceuticals Inc. stock double in the next yearPortfolio Growth Summary & Real-Time Buy Signal Notifications - خودرو بانک
Key metrics from Madrigal Pharmaceuticals Inc.’s quarterly dataWeekly Profit Recap & Reliable Volume Spike Alerts - Newser
Sector ETF performance correlation with Madrigal Pharmaceuticals Inc.Weekly Stock Report & Weekly Breakout Opportunity Watchlist - Newser
Will Madrigal Pharmaceuticals Inc. see short term momentum2025 Technical Overview & Community Consensus Picks - Newser
Intraday pattern recognizer results for Madrigal Pharmaceuticals Inc.July 2025 Decliners & Daily Stock Trend Reports - Newser
Madrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
How to forecast Madrigal Pharmaceuticals Inc. trends using time seriesJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - Newser
Will Madrigal Pharmaceuticals Inc. stock go up soonEarnings Miss & Smart Allocation Stock Reports - Newser
Real time pattern detection on Madrigal Pharmaceuticals Inc. stockWeekly Trade Report & Low Drawdown Momentum Ideas - Newser
Is Madrigal Pharmaceuticals Inc. affected by consumer sentiment2025 Key Lessons & Reliable Entry Point Trade Alerts - خودرو بانک
What are Madrigal Pharmaceuticals Inc.’s recent SEC filings showingWeekly Stock Analysis & Community Consensus Trade Signals - خودرو بانک
Using Python tools to backtest Madrigal Pharmaceuticals Inc. strategiesJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - Newser
How to manage a losing position in Madrigal Pharmaceuticals Inc.July 2025 Rallies & Verified Momentum Stock Ideas - Newser
Should you wait for a breakout in Madrigal Pharmaceuticals Inc.2025 Key Highlights & Capital Protection Trading Alerts - Newser
Can Madrigal Pharmaceuticals Inc. maintain sales growth2025 Earnings Impact & Daily Profit Focused Stock Screening - خودرو بانک
What machine learning models say about Madrigal Pharmaceuticals Inc.July 2025 Big Picture & Trade Opportunity Analysis - Newser
Trend analysis for Madrigal Pharmaceuticals Inc. this weekWatch List & Daily Chart Pattern Signals - Newser
Should you wait for a breakout in Madrigal Pharmaceuticals Inc2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Is Madrigal Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Retail & Real-Time Chart Pattern Alerts - Newser
Madrigal Pharmaceuticals Inc Azioni (MDGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):